Chronic hepatitis is often associated with neuropsychiatric disorders. Interferon (IFN) is the
drug most widely used to treat this disease, and its side effects, such as depression, often …

Background: Several studies found a high incidence rate of neuro-psychiatric complications
during long-term therapy with interferon alpha (IFNα), eg slowness, severe fatigue …

Background: Interferon-Alfa (IFN-α) has been the mainstay of treatment for chronic hepatitis
C. It has the potential to alter the course of chronic hepatitis C and prevent complications …

IFN alpha treatment is able to produce dose-related side effects, such as depression, in the
central nervous system. We assessed the effects on depression of four different types of IFN …

Immunotherapy with interferon-alpha (IFNα) may induce depressive symptoms, anxiety and
major depression when administered for at least 1–3 months at a dose of 3–10 MUI daily …

Psychiatric symptoms during interferon (IFN) therapy for viral hepatitis have been a crucial
problem in consultation‐liaison psychiatry. However, there have been few studies on …

Thirty-nine patients with hepatitis C viral infection on interferon-α (IFN-α) therapy were
monitored weekly using the Beck Depression Inventory (BDI). Thirteen of thirty-nine patients …

BACKGROUND: This study is aim to investigate concurrent long-term psychiatric, cognitive
and neurophysiological measures of α-IFN neurotoxicity in the treatment of chronic viral …

The number of patients treated with interferon (IFN) has increased markedly in Japan since
1992, when the Health and Welfare Ministry approved the use of IFN for treating chronic …

Interferon (IFN) therapy has been associated with the development of Major Depressive
Disorder (MDD) when given to patients with hepatitis C (HCV). The incidence, time course …